Dignitana
1.02
SEK
+4.62 %
DIGN
First North Stockholm
Medical Equipment & Services
Health Care
3 following
+4.62%
-32%
-15%
-42.37%
-53.21%
-53%
-86.58%
-88.03%
-65.22%
dignitana.com/investor-relations
Dignitana is active in medical technology. The company's main focus is to develop, manufacture, and distribute medical aids that are primarily used as a scalp cooling system in chemotherapy treatment, where the purpose is to eliminate or greatly reduce hair loss. The company operates worldwide. Dignitana was founded in 2007 has its headquarters located in Lund.
Revenue
86.06M
EBIT %
-17.46 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
DIGN
Daily low / high price
0.97 / 1.02
SEK
Market cap
82.15M SEK
Turnover
8.6K SEK
Volume
8.5K
Latest videos
Financial calendar
Annual report
20.02.2025
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Agartha AB | 29.8 % | 29.8 % |
| Swedbank Robur Microcap | 7.7 % | 7.7 % |
| Försäkringsbolaget Avanza Pension | 7.3 % | 7.3 % |
| UBS Financial Services INC | 5.2 % | 5.2 % |
| Handelsbanken Microcap Sverige | 3.8 % | 3.8 % |
| Försäkringsaktiebolaget Skandia | 3.4 % | 3.4 % |
| LQM Lundia AB | 3.3 % | 3.3 % |
| Magbaleo | 2.5 % | 2.5 % |
| Technovobis AB | 2.2 % | 2.2 % |
| FCG Fonder | 1.9 % | 1.9 % |
ShowingAll content types
Dignitana AB Publishes Q3 2024 Interim Report
Dignitana AB (publ) appoints Nomination Committee for Annual General Meeting 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools